<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01947127</url>
  </required_header>
  <id_info>
    <org_study_id>793/2012</org_study_id>
    <nct_id>NCT01947127</nct_id>
  </id_info>
  <brief_title>Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department</brief_title>
  <official_title>Can Venous Lactate Predict the Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients Without Hemodynamic Shock in Emergency Department?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the role of initial venous lactate in predicting the severity progression to
      overt septic shock and 30-day mortality in non-elderly patients without hemodynamic shock who
      suspected to have acute infections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood lactate is one of the markers that can predict the organ failures and mortality in
      emergency department (ED) patients with sepsis. Regarding its predictive role in the clinical
      deterioration in normotensive sepsis patients, a recent prospective observational study of
      the patients with moderately-high serum lactate (2.0-3.9 mmol/L) showed that one-forth of the
      patients eventually developed progressive organ dysfunctions or required vasopressor or
      mechanical ventilator. Unfortunately, low serum lactate (&lt; 2.5 mmol/L) was still found up to
      50% of overt septic shock patients, even in vasopressor-dependent cases. For the prognostic
      role on mortality, numbers of articles showed that blood lactate can also predict death in
      sepsis patients, especially in those who are elderly and critically-ill. However, no previous
      study was done in younger patients since lactate kinetics in the body may differ among the
      age groups. The primary aim of our study is to investigate the role of initial venous lactate
      levels in predicting the chance of severity progression to overt septic shock especially in
      non-elderly patients who suspected to have acute infections and without hemodynamic shock in
      ED. The secondary outcomes are to evaluate its prognostic role on hospital length of stay and
      30-day mortality of this target population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Proportion of the Patients Who Require Vasopressor/Mechanical Ventilator</measure>
    <time_frame>72 hours after venous lactate measurement</time_frame>
    <description>Proportion of the patients in each cohort who require vasopressor/mechanical ventilator to maintain their vital signs in the next 72 hours after venous lactate measurement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality Rates</measure>
    <time_frame>30 days after the day of presentation to the emergency department</time_frame>
    <description>Electronic database retrieval of in- and outpatient clinical records together with telephone follow-ups to the patients or their contact personnel are employed to every case in the next 30 days after the day of presentation to the emergency department to identify the deceased cases. All-cause mortality rates of each cohort will be compared by the survival analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Patients will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
    <description>Numbers of days spent in the hospital since the emergency department arrival to hospital discharge</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">458</enrollment>
  <condition>Sepsis</condition>
  <condition>Disease Progression</condition>
  <condition>Septic Shock</condition>
  <condition>Fatal Outcome</condition>
  <arm_group>
    <arm_group_label>High lactate</arm_group_label>
    <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low lactate</arm_group_label>
    <description>Initial venous lactate level less than 2.0 mmol/L</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Venous blood lactate obtained by standard venipuncture together with other essential blood
      works before giving antibiotics or intravenous fluid, if required. Lactate level is measured
      by EpocÂ® point-of-care blood analyzer (Epocal Inc., Ottawa, ON, Canada) within 5 minutes
      after obtaining the venous sample without any preservative.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Emergency department patients of King Chulalongkorn Memorial Hospital (a 1500-bed,
        tertiary-care, university-affiliated urban hospital)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 65 years

          -  Confirmed or suspected diagnoses of acute infections (within 7 days)

          -  Major infections (e.g. Acute pyelonephritis, Acute bronchitis/pneumonia, Acute
             hepatobiliary tract infections, intrabdominal abscesses, meningitis and other central
             nervous system infections, soft tissue infections involving more than 10 square
             centimeters of the skin surface or deeper down beyond the dermis, significant tropical
             infections; dengue fever, leptospirosis, typhus fevers, or high fever from any
             infectious sources)

          -  Systolic blood pressure more than 90 mmHg at presentation

          -  Mean arterial pressure more than 70 mmHg at presentation

        Exclusion Criteria:

          -  Duplicated cases that have participated in this study during the study period

          -  Overt organ hypoperfusion (e.g. cold, clammy or mottling skin, altered mental status;
             Glasgow Coma Scale equal to or less than 12 or decrease &gt; 1 compared with the
             baseline)

          -  Pulse oximetry equal to or less than 90% at ambient air

          -  received intravenous fluid more than 10 ml/kg prior to the venous blood sampling

          -  received intravenous antibiotics for more than 1 hours prior to the venous blood
             sampling

          -  Minor infections (e.g. uncomplicated upper respiratory tract infections,
             gastroenteritis, minor skin infections)

          -  currently taking antiretroviral drugs

          -  having or suspicious of having seizures in the past 72 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khrongwong Musikatavorn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine, Facalty of medicine, Chulalongkorn University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Medicine Unit, King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Patumwan</city>
        <state>Bangkok</state>
        <zip>11130</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>Musikatavorn K, Thepnimitra S, Komindr A, Puttaphaisan P, Rojanasarntikul D. Venous lactate in predicting the need for intensive care unit and mortality among nonelderly sepsis patients with stable hemodynamic. Am J Emerg Med. 2015 Jul;33(7):925-30. doi: 10.1016/j.ajem.2015.04.010. Epub 2015 Apr 10.</citation>
    <PMID>25936479</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2013</study_first_submitted>
  <study_first_submitted_qc>September 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2013</study_first_posted>
  <results_first_submitted>April 21, 2015</results_first_submitted>
  <results_first_submitted_qc>April 21, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 7, 2015</results_first_posted>
  <last_update_submitted>October 21, 2016</last_update_submitted>
  <last_update_submitted_qc>October 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Khrongwong Musikatavorn, MD.</investigator_full_name>
    <investigator_title>Khrongwong Musikatavorn, MD</investigator_title>
  </responsible_party>
  <keyword>Lactate</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Septic shock</keyword>
  <keyword>Disease progression</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment started at April 2013 to October 2014 at King Chulalongkorn Memorial Hospital, a university-affiliated, 1,500 bed, tertiary care urban hospital</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>High Lactate</title>
          <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
        </group>
        <group group_id="P2">
          <title>Low Lactate</title>
          <description>Initial venous lactate level less than 2.0 mmol/L</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="166"/>
                <participants group_id="P2" count="292"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
                <participants group_id="P2" count="249"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Data loss</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Lactate</title>
          <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
        </group>
        <group group_id="B2">
          <title>Low Lactate</title>
          <description>Initial venous lactate level less than 2.0 mmol/L</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="143"/>
            <count group_id="B2" value="249"/>
            <count group_id="B3" value="392"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.0" spread="13.7"/>
                    <measurement group_id="B2" value="42.8" spread="14.4"/>
                    <measurement group_id="B3" value="44.0" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Thai and Southeast Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Thailand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of the Patients Who Require Vasopressor/Mechanical Ventilator</title>
        <description>Proportion of the patients in each cohort who require vasopressor/mechanical ventilator to maintain their vital signs in the next 72 hours after venous lactate measurement.</description>
        <time_frame>72 hours after venous lactate measurement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Lactate</title>
            <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
          </group>
          <group group_id="O2">
            <title>Low Lactate</title>
            <description>Initial venous lactate level less than 2.0 mmol/L</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of the Patients Who Require Vasopressor/Mechanical Ventilator</title>
          <description>Proportion of the patients in each cohort who require vasopressor/mechanical ventilator to maintain their vital signs in the next 72 hours after venous lactate measurement.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="249"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause Mortality Rates</title>
        <description>Electronic database retrieval of in- and outpatient clinical records together with telephone follow-ups to the patients or their contact personnel are employed to every case in the next 30 days after the day of presentation to the emergency department to identify the deceased cases. All-cause mortality rates of each cohort will be compared by the survival analysis.</description>
        <time_frame>30 days after the day of presentation to the emergency department</time_frame>
        <population>Four patients out of 392 patients were excluded from secondary (mortality) outcome analysis due to unknown mortality status. As a result, 388 patients (139 in high lactate group and 249 in low lactate group) were available for mortality outcome analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>High Lactate</title>
            <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
          </group>
          <group group_id="O2">
            <title>Low Lactate</title>
            <description>Initial venous lactate level less than 2.0 mmol/L</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality Rates</title>
          <description>Electronic database retrieval of in- and outpatient clinical records together with telephone follow-ups to the patients or their contact personnel are employed to every case in the next 30 days after the day of presentation to the emergency department to identify the deceased cases. All-cause mortality rates of each cohort will be compared by the survival analysis.</description>
          <population>Four patients out of 392 patients were excluded from secondary (mortality) outcome analysis due to unknown mortality status. As a result, 388 patients (139 in high lactate group and 249 in low lactate group) were available for mortality outcome analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="249"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Length of Stay</title>
        <description>Numbers of days spent in the hospital since the emergency department arrival to hospital discharge</description>
        <time_frame>Patients will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Lactate</title>
            <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
          </group>
          <group group_id="O2">
            <title>Low Lactate</title>
            <description>Initial venous lactate level less than 2.0 mmol/L</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Length of Stay</title>
          <description>Numbers of days spent in the hospital since the emergency department arrival to hospital discharge</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="249"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="2" upper_limit="14"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Overall study period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>High Lactate</title>
          <description>Initial venous lactate level equal to or more than 2.0 mmol/L</description>
        </group>
        <group group_id="E2">
          <title>Low Lactate</title>
          <description>Initial venous lactate level less than 2.0 mmol/L</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="249"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="249"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>1. This was an observational study that did not evaluate the aggressiveness of the treatment strategies. 2. The study was done in a single, urban, university hospital. 3. The staging of co-morbidity (e.g. cancers) was not well-categorized.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Khrongwong Musikatavorn, M.D.</name_or_title>
      <organization>Faculty of Medicine, Chulalongkorn University</organization>
      <phone>+6622564553</phone>
      <email>kmusikatavorn@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

